Concepedia

Josh Snyder

JS

8

Publications

467

Citations

8

H-Index

2015

Active since

Affiliations

Astellas Pharma (United States)(Current)

University of Santa Monica

Josh Snyder is an author at Astellas Pharma (United States) specializing in medicine, drug discovery, and radiation oncology.

Top concepts

Publications per year

2015–2024

8

Publications

8

Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody–Drug Conjugates

Hui Zhao, John Atkinson, Sara Gulesserian et al. · Cancer Research · 2018 · 120 citations

GPT-4o System Card

OpenAI, A. M. Hurst, Adam Lerer et al. · arXiv (Cornell University) · 2024 · 87 citations · Full text

, , +18

Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i> , a New Urothelial Cancer Biomarker

Kendall Morrison, Pia M. Challita-Eid, Arthur Raitano et al. · Molecular Cancer Therapeutics · 2016 · 65 citations · Full text

Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia

Hui Zhao, Sara Gulesserian, Sathish Kumar Ganesan et al. · Molecular Cancer Therapeutics · 2017 · 63 citations · Full text

Investigation of Hydrophilic Auristatin Derivatives for Use in Antibody Drug Conjugates

Brian A. Mendelsohn, Stuart D. Barnscher, Josh Snyder et al. · Bioconjugate Chemistry · 2017 · 45 citations

, , +17

Rows per page

1–5 of 8